Advertisement
|
|
|
|
|
Free Trial
Description: Edmundo Muniz is Tigris Pharmaceuticals CEO/President. With a Lead411 subscription, Tigris Pharmaceuticals email addresses ( @tigrispharma.com ) of the executives are viewable. Other information includes Edmundo Muniz email, phone, and extension.
Be sure to check our Linkedin tab on the company page. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to Muniz can be found at Executive Directory - Muniz.
|
Add Edmundo Muniz Information
Site Reference: http://www.tigrispharma.com/pr_090105.html
Edmundo Muniz Tigris' President and Chief Executive Officer. No drug therapies are currently approved for anal HSIL, the pathological precursor to anal cancer associated with human papillomavirus (HPV) infection, and surgical intervention is associated with significant morbidity. Anal HSIL is the second potential indication for A-007, which is scheduled to enter a multi-center placebo-controlled Phase II trial for high-grade cervical intraepithelial neoplasia (CIN) in Q4 2005. About Tigris Pharmaceuticals, Inc. Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical company that acquires the rights to commercially develop therapeutic technologies to address unmet medical needs. Tigris is currently developing A-007, a topical treatment for pre-cancerous and cancerous anogenital lesions associated with the HPV. The company's mission is to efficiently move its existing and future technologies through the various stages of clinical development in order to meet patients' needs for safe and effective treatments of human illnesses. Contact: Edmundo Muniz
|
|
| Copyright 2010 Lead411 | Santa Barbara, CA |
|
|
|
|
Advertisement
|
